In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
November 9th, 2004 | 23 | Yes |
189954-96-9; C18363; Firocoxib
189954-96-9; D03712; Equioxx (TN) [veterinary]; Firocoxib (USAN/INN)
3-(Cyclopropylmethoxy)-4-(4-methylsulfonylphenyl)-5,5-dimethylfuranone
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 2.72 | -1.29 | -17.26 | 0 | 5 | 0 | 69 | 336.409 | 5 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
Therapy | analgesic, antiinflammatory, antipyretic, COX-II inhibitor | SMDC Pharmakon |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
PGH2-7-E | Cyclooxygenase-2 (cluster #7 Of 8), Eukaryotic | Eukaryotes | 140 | 0.42 | Binding ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
PGH2_HUMAN | P35354 | Cyclooxygenase-2, Human | 140 | 0.42 | Binding ≤ 1μM |
PGH2_HUMAN | P35354 | Cyclooxygenase-2, Human | 140 | 0.42 | Binding ≤ 10μM |
Description | Species |
---|---|
Nicotinamide salvaging | |
Synthesis of 15-eicosatetraenoic acid derivatives | |
Synthesis of Prostaglandins (PG) and Thromboxanes (TX) |